Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury
Study on the Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury: A Pilot Study
1 other identifier
interventional
32
1 country
1
Brief Summary
Purpose: to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction. The aim is to improve postural control in both seated and standing positions and to maintain and improve cognitive capacity. Material and methods: one group (experimental group) will receive a total of 8 one-hour sessions or 16 half-hour sessions, depending on their individual needs, for 8 weeks using the Nintendo Switch. The other group (control group) will continue to receive their conventional scheduled therapy. Measures: Abilhand, MEC-Lobo, FIST, Fugl-Meyer, Berg Balance Scale and CSQ-8.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFebruary 29, 2024
February 1, 2024
Same day
January 30, 2024
February 28, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Abilhand
It is an assessment test that measures the degree of difficulty perceived by the patient in performing the 23 activities of daily living.
Pre-intervention and post-intervention (up to 1-2 weeks)
MEC-Lobo
This is a scale that allows us to evaluate the cognitive status of patients. The lower the score, the greater the cognitive impairment.
Pre-intervention and post-intervention (up to 1-2 weeks)
Function in Sitting Test (FIST)
It is a scale that assesses the postural control deficits presented by the patient in sedentary position in the event of imbalance, reaching on the floor, etc.
Pre-intervention and post-intervention (up to 1-2 weeks)
Fugl-Meyer
This scale assesses the patient's motor function, sensory function, muscle balance, range of joint mobility and joint pain.
Pre-intervention and post-intervention (up to 1-2 weeks)
Berg Balance Scale (BBS)
The scale is used to measure balance mainly in standing position in patients with different types of pathologies.
Pre-intervention and post-intervention (up to 1-2 weeks)
Secondary Outcomes (1)
Client Satisfaction Questionnaire (CSQ-8)
Post-intervention (up to 1-2 weeks)
Study Arms (2)
Control Group
ACTIVE COMPARATORControl Group (CG) which received their usual sessions of conventional therapy.
Experimental Group
EXPERIMENTALExperimental Group (EG) which received therapy with Nintendo Switch plus their usual sessions of conventional therapy.
Interventions
Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise.
Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise plus one hour a week of Nintendo Switch.
Eligibility Criteria
You may qualify if:
- Adult men and women, over 30 years of age who have suffered an acquired brain injury.
- Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35).
- Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy).
- Agree to participate voluntarily by signing the informed consent form.
You may not qualify if:
- Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35).
- Present aphasia of comprehension or expression.
- Present associated neurodegenerative pathology.
- Present any pathology underlying the acquired brain damage (diabetes, heart disease, COPD, etc.), heart disease, COPD, etc.).
- Voluntarily refuse to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Rey Juan Carlos
Móstoles, Madrid, 28933, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isabel Quirosa Galan, MsC
Universidad Rey Juan Carlos
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Occupational Therapist, MsC
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 29, 2024
Study Start
February 1, 2024
Primary Completion
February 1, 2024
Study Completion
January 1, 2025
Last Updated
February 29, 2024
Record last verified: 2024-02